{"id":"NCT04838626","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection","officialTitle":"Phase II/III Study for Evaluation of the Diagnostic Performance of [18F]CTT1057 PET Imaging for the Detection of PSMA Positive Tumors Using Histopathology as a Standard of Truth","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2021-09-07","primaryCompletion":"2023-11-24","completion":"2023-11-24","firstPosted":"2021-04-09","resultsPosted":"2024-12-18","lastUpdate":"2025-05-16"},"enrollment":195,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Prostatic Neoplasms","Prostate Cancer"],"interventions":[{"type":"DRUG","name":"[18F]CTT1057","otherNames":["Single intravenous dose of approximately 370 Mega-Becquerel (MBq) and subsequent PET/CT scan"]}],"arms":[{"label":"PET/CT imaging with [18F]CTT1057","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate the diagnostic performance of \\[18F\\]CTT1057 as a PET imaging agent for detection and localization of PSMA positive tumors using histopathology as Standard of Truth (SoT). Tissue specimens from both the primary tumor and pelvic lymph nodes dissected during surgery from patients with newly-diagnosed high-risk prostate cancer (PCa) were used for the histopathology assessments.","primaryOutcome":{"measure":"Patient-level Sensitivity of Vidoflufolastat (18F) - % Sensitivity","timeFrame":"vidoflufolastat (18F)7 PET imaging acquired at Day 1 assessed against histopathology as Standard of Truth (SoT) obtained during surgery within 6 weeks from vidoflufolastat (18F) scan","effectByArm":[{"arm":"Central Reader 1","deltaMin":88.8,"sd":null},{"arm":"Central Reader 2","deltaMin":88.2,"sd":null},{"arm":"Central Reader 3","deltaMin":86.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":16,"countries":["United States","France","Italy","Spain","Switzerland"]},"refs":{"pmids":[],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=2411"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":184},"commonTop":["Hypertension","Dizziness","Presyncope","Abdominal pain","Diarrhoea"]}}